FI932573A0 - Maenniskans dopamin-D4-receptor och anvaendningar daerav - Google Patents

Maenniskans dopamin-D4-receptor och anvaendningar daerav

Info

Publication number
FI932573A0
FI932573A0 FI932573A FI932573A FI932573A0 FI 932573 A0 FI932573 A0 FI 932573A0 FI 932573 A FI932573 A FI 932573A FI 932573 A FI932573 A FI 932573A FI 932573 A0 FI932573 A0 FI 932573A0
Authority
FI
Finland
Prior art keywords
receptor
dopamine
maenniskans
anaeraving
daerav
Prior art date
Application number
FI932573A
Other languages
English (en)
Other versions
FI932573A (fi
Inventor
Olivier Civelli
Tol Hubert Van
Original Assignee
Oregon State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oregon State filed Critical Oregon State
Publication of FI932573A0 publication Critical patent/FI932573A0/fi
Publication of FI932573A publication Critical patent/FI932573A/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C12Q1/683—Hybridisation assays for detection of mutation or polymorphism involving restriction enzymes, e.g. restriction fragment length polymorphism [RFLP]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9406—Neurotransmitters
    • G01N33/9413—Dopamine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Compounds Of Unknown Constitution (AREA)
FI932573A 1990-12-07 1993-06-04 Maenniskans dopamin-d4-receptor och anvaendningar daerav FI932573A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/626,618 US5422265A (en) 1990-12-07 1990-12-07 DNA sequence for the human dopamine receptor D4 and expression thereof in mammalian cells
PCT/US1991/009308 WO1992010571A1 (en) 1990-12-07 1991-12-06 Human dopamine d4 receptor and its uses

Publications (2)

Publication Number Publication Date
FI932573A0 true FI932573A0 (fi) 1993-06-04
FI932573A FI932573A (fi) 1993-07-09

Family

ID=24511138

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932573A FI932573A (fi) 1990-12-07 1993-06-04 Maenniskans dopamin-d4-receptor och anvaendningar daerav

Country Status (11)

Country Link
US (2) US5422265A (fi)
EP (1) EP0574406B1 (fi)
JP (1) JP2966093B2 (fi)
AT (1) ATE196925T1 (fi)
AU (1) AU652211B2 (fi)
CA (1) CA2097698C (fi)
DE (1) DE69132447T2 (fi)
DK (1) DK0574406T3 (fi)
FI (1) FI932573A (fi)
NO (1) NO311363B1 (fi)
WO (1) WO1992010571A1 (fi)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6277591B1 (en) 1988-11-18 2001-08-21 Oregon Health Science University Dopamine receptors and genes
US5569601A (en) 1990-12-07 1996-10-29 State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education On Behalf Of The Oregon Health Sciences University Human dopamine receptor and its uses
AU673810B2 (en) * 1991-10-16 1996-11-28 Chiron Corporation Secreted Mac-2-binding glycoprotein
US5766948A (en) * 1993-01-06 1998-06-16 The Regents Of The University Of California Method for production of neuroblasts
US6486310B1 (en) * 1993-01-28 2002-11-26 Washington University Gene encoding the rat dopamine D4 receptor
WO1994020497A1 (en) * 1993-03-01 1994-09-15 Merck Sharp & Dohme Limited Pyrrolo-pyridine derivatives
US5576319A (en) * 1993-03-01 1996-11-19 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
US5622950A (en) * 1993-03-01 1997-04-22 Merck, Sharp & Dohme Ltd. Pyrrolo-pyridine derivatives
US5468615A (en) * 1993-07-01 1995-11-21 The Upjohn Company Binding assay employing a synthetic gene for D4 dopamine receptors
EP0804569A2 (en) * 1993-09-28 1997-11-05 Allelix Biopharmaceuticals Inc. Expression of human d 4? dopamine receptors in stable cell lines
US5994503A (en) * 1995-03-27 1999-11-30 Yale University Nucleotide and protein sequences of lats genes and methods based thereon
US6531314B1 (en) * 1996-12-10 2003-03-11 Merck & Co., Inc. Growth hormone secretagogue receptor family
AU3230797A (en) * 1996-06-05 1998-01-05 Chiron Corporation Dna encoding dp. 75 and a process for its use
AUPO427596A0 (en) * 1996-12-20 1997-01-23 Cooperative Research Centre For Tropical Plant Pathology Anti-microbial protein
US6645726B1 (en) 1998-08-10 2003-11-11 Merck & Co., Inc. Canine growth hormone secretagogue receptor
US6783973B1 (en) 2000-09-12 2004-08-31 Oregon Health & Science University Mammalian catecholamine receptor genes and uses
US7381542B2 (en) * 2001-07-09 2008-06-03 Oregon Health & Science University Nucleic acids encoding a biogenic amine receptor
US20080213271A1 (en) * 2005-05-05 2008-09-04 Center For Addiction And Mental Health Compositions and Methods For Modulating Dopamine Nerutransmission
EP2294081B1 (en) * 2008-06-12 2016-12-14 Centre For Addiction And Mental Health Compositions and methods for modulating d1-d2 dopamine receptor interaction and function

Also Published As

Publication number Publication date
AU9140391A (en) 1992-07-08
NO932057D0 (no) 1993-06-04
FI932573A (fi) 1993-07-09
NO932057L (no) 1993-08-09
DE69132447D1 (de) 2000-11-16
ATE196925T1 (de) 2000-10-15
US5422265A (en) 1995-06-06
WO1992010571A1 (en) 1992-06-25
AU652211B2 (en) 1994-08-18
US5594108A (en) 1997-01-14
JPH06503958A (ja) 1994-05-12
DK0574406T3 (da) 2000-11-13
CA2097698C (en) 1999-06-01
DE69132447T2 (de) 2001-03-08
EP0574406B1 (en) 2000-10-11
JP2966093B2 (ja) 1999-10-25
CA2097698A1 (en) 1992-06-08
NO311363B1 (no) 2001-11-19
EP0574406A1 (en) 1993-12-22

Similar Documents

Publication Publication Date Title
FI932573A0 (fi) Maenniskans dopamin-D4-receptor och anvaendningar daerav
CA2133843A1 (en) Melanocyte stimulating hormone receptor and uses
WO1994003602A3 (en) A novel human dopamine receptor and its uses
ES2118066T3 (es) Sintesis y aislamiento, exentos de celulas, de nuevos genes y polipeptidos.
DK0977874T3 (da) Svækket salmonella-stamme anvendt som bæremedium til oral immunisering
NZ336146A (en) Substituted nitrogen containing heterocycles as inhibitors of p38 protein kinase
DK1792982T3 (da) Codon-optimeret phosphatase og ekspression heraf i gær
ATE368682T1 (de) Als 2f1 bezeichnetes rezeptorprotein
ES8604265A1 (es) Un metodo para preparar un peptido o una sal no toxica del mismo.
PT851926E (pt) Variantes do interferao-gama (rhu-ifn-gama) recombinante humano com estabilidade termica melhorada
HK1023143A1 (en) Intracellular production of hepatitis c e2 truncated polypeptid
DK0856581T3 (da) Stabilt transficerede cellelinjer, der udtrykker GABA-A-receptorer
NO892029L (no) Fremgangsmaate ved spesifikk genetisk manipulering av mikroorganisme.
DK0843731T3 (da) Adenovirusvektorer til genterapi
NO800724L (no) Fremgangsmaate til fremstilling peptider med ubiquitinlignende aktivitet
CA2133845A1 (en) Adrenocorticotrophic hormone receptor and uses
EP0299050A4 (en) ISOLATION OF SINGLE-CHAIN PROTEINS WITH FSH-SUPPRESSING ACTIVITY FROM FOLLICULAR LIQUID.
GB9919409D0 (en) Baculovirus expression system
ATE111158T1 (de) Humaner papillomvirus typ 41.
HU9500619D0 (en) Cloning and expression of b-app-c100 receptor
GB744460A (en) Improvements in or relating to electrical vibrators
DK336887A (da) Enzymer